16 reports of this reaction
3.6% of all MANGANESE SULFATE reports
#8 most reported adverse reaction
ANAEMIA is the #8 most commonly reported adverse reaction for MANGANESE SULFATE, manufactured by BM Private Limited. There are 16 FDA adverse event reports linking MANGANESE SULFATE to ANAEMIA. This represents approximately 3.6% of all 450 adverse event reports for this drug.
Patients taking MANGANESE SULFATE who experience anaemia should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
ANAEMIA is moderately reported among MANGANESE SULFATE users, representing a notable but not dominant share of adverse events.
In addition to anaemia, the following adverse reactions have been reported for MANGANESE SULFATE:
The following drugs have also been linked to anaemia in FDA adverse event reports:
ANAEMIA has been reported as an adverse event in 16 FDA reports for MANGANESE SULFATE. This does not prove causation, but indicates an association observed in post-market surveillance data.
ANAEMIA accounts for approximately 3.6% of all adverse event reports for MANGANESE SULFATE, making it a notable side effect.
If you experience anaemia while taking MANGANESE SULFATE, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.